Dec 08,2021

New insulin management solution to come out of Health2Sync, Sanofi's extended partnership

Health2Sync, a digital health startup based in Taiwan, and French multinational pharmaceutical firm Sanofi have extended their collaboration to soon come up with and market a new insulin management solution. According to a press statement, Health2Sync will develop an insulin management solution with titration algorithms, which the company said will be "the first of its kind in Asia".

COLLABORATION PARTNERSHIP

#r&d

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 10,2021

Clinical Study of a High Accuracy Green Design Blood Glucose Monitor Using an Innovative Optical Transmission Absorbance System

Blood glucose monitoring (BGM) is essential for glycemic control in diabetic therapy. Followingly, accurate sensors are required for both daily personal and clinical use. The frequency of sensor use in patients with diabetes facilitates the use of disposable components. However, BGM systems are not exempt from green innovation sustainability initiatives.

CLINICAL STUDY

#bgm

View Analyst & Ambassador Comments
Go to original news
Dec 10,2021

Needle Technology for Insulin Administration: A Century of Innovation

Innovations in syringe and pen needle (PN) technology over the last 100 years have led to important advances in insulin delivery for people with diabetes, paralleling the strides made in developing recombinant DNA human insulin and insulin analogs with varying onset and duration of action. In this review, the history of advances in insulin delivery is described, focusing on progress in syringe, needle, and PN technologies.These developments, coupled with innovations in needle/PN wall and tip structure, have led to improved injection experience for people with diabetes. It is also important to acknowledge the role of injection technique education, together with these advances in injection technology, for improving clinical outcomes and patient satisfaction. With continued projected growth of diabetes prevalence, particularly in developing countries where expensive and complex insulin delivery systems may not be practical, insulin syringes and pens will continue to serve as reliable and cost-effective means of insulin delivery for people with diabetes.

CLINICAL STUDY

#insulin pen

#insulin pump

#cgm

View Analyst & Ambassador Comments
Go to original news
Dec 14,2021

Virta Health Reveals Triple-Digit Growth With Health Plans Amid Industry Shift Towards Diabetes Reversal

Today Virta Health, the leader in type 2 diabetes reversal, announced it now works with more than 20 national and regional health plans, marking 133% year-over-year growth with large insurer customers. Of these partners, nearly half—including Humana and Providence Health Plan—now offer Virta’s diabetes reversal treatment to their self-funded employer groups, representing thousands of companies and over 5M covered lives.

View Analyst & Ambassador Comments
Go to original news
Dec 15,2021

Medtronic Diabetes receives FDA warning letter

Medtronic plc(opens new window) (NYSE:MDT) today announced it received a warning letter from the U.S. Food and Drug Administration (FDA) on December 9 for the company's Northridge, California, facility, the headquarters for its Diabetes Business(opens new window). The warning letter was issued following an inspection that concluded in July 2021 related to recalls of the MiniMed™ 600 series insulin infusion pump, and a remote controller device for MiniMed™ 508 and Paradigm™ pumps.

PRODUCT

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Dec 15,2021

An Adaptive, Algorithm-based Text Message Intervention to Promote Health Behavior Adherence in Type 2 Diabetes: Treatment Development and Proof-of-Concept Trial

Most individuals with type 2 diabetes (T2D) struggle to adhere to one or more health behaviors. Text message interventions (TMIs) have the potential to improve adherence but have had mixed effects on diet and activity in T2D. We developed an eight-week, adaptive, algorithm-driven TMI to promote physical activity, diet, self-care, and well-being. Then, in a single-arm trial, we assessed its feasibility, acceptability, and preliminary efficacy in 15 individuals with T2D and suboptimal adherence.

CLINICAL STUDY

#virtual care

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 15,2021

Reliability of Inpatient CGM: Comparison to Standard of Care

Optimal inpatient glycemic management targets a blood glucose (BG) of 140-180 mg/dL and is an important safety measure for hospitalized patients with hyperglycemia. Traditional barriers to appropriate insulin administration include incorrect timing of prandial insulin administration, failure to administer basal insulin to persons with insulin deficiency/type 1 diabetes mellitus (DM), and inaccurate insulin dosing or timing resulting in hypoglycemia. Given the ongoing rapid assimilation of technology to manage our patients with DM, we investigated the use of continuous glucose monitoring (CGM) in the inpatient setting as a potential solution to traditional barriers to optimal hyperglycemia management for inpatient care. In this study, we evaluated the efficacy of use of inpatient CGM for insulin dosing in comparison with current standard of care and whether CGM could aid in minimizing hypoglycemic events.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Dec 16,2021

Bigfoot Biomedical® Adds Depth with Experienced, Senior New Hires

With its Bigfoot Unity™ Diabetes Management Program fully commercial, Bigfoot looks to broaden access to diabetes centers, endocrinology practices and health systems in 2022, as well as expand its development pipeline.

#product & service

View Analyst & Ambassador Comments
Go to original news
Dec 16,2021

Teladoc Health Improves Access to Whole-Person Care Through an Expanded Partnership with National Labor Alliance

Teladoc Health, the global leader in whole-person virtual care, today announced an expanded partnership with the National Labor Alliance of Health Care Coalitions (NLA), the largest alliance of labor unions and labor management coalitions, to offer its full suite of virtual care products and services. Teladoc Health’s general medical, specialty care, mental health, expert medical services, chronic condition management, and virtual primary care programs will now be available as part of the exclusive endorsement to the NLA’s Coalitions, their member Funds and their six million members across all 50 states.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 20,2021

DayTwo Makes Reaching Diabetes Remission Easier than Ever

Big news in the world of DayTwo! Starting mid-December, our app will be featuring a newly redesigned progress tab that helps members stay on target to control their blood sugar, lower their A1C, and reduce their medications.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES